199 related articles for article (PubMed ID: 21846830)
1. Novel irreversible small molecule inhibitors of replication protein A display single-agent activity and synergize with cisplatin.
Neher TM; Bodenmiller D; Fitch RW; Jalal SI; Turchi JJ
Mol Cancer Ther; 2011 Oct; 10(10):1796-806. PubMed ID: 21846830
[TBL] [Abstract][Full Text] [Related]
2. Replication Protein A Availability during DNA Replication Stress Is a Major Determinant of Cisplatin Resistance in Ovarian Cancer Cells.
Bélanger F; Fortier E; Dubé M; Lemay JF; Buisson R; Masson JY; Elsherbiny A; Costantino S; Carmona E; Mes-Masson AM; Wurtele H; Drobetsky E
Cancer Res; 2018 Oct; 78(19):5561-5573. PubMed ID: 30072396
[TBL] [Abstract][Full Text] [Related]
3. Replication protein A: single-stranded DNA's first responder: dynamic DNA-interactions allow replication protein A to direct single-strand DNA intermediates into different pathways for synthesis or repair.
Chen R; Wold MS
Bioessays; 2014 Dec; 36(12):1156-61. PubMed ID: 25171654
[TBL] [Abstract][Full Text] [Related]
4. Cellular functions of human RPA1. Multiple roles of domains in replication, repair, and checkpoints.
Haring SJ; Mason AC; Binz SK; Wold MS
J Biol Chem; 2008 Jul; 283(27):19095-111. PubMed ID: 18469000
[TBL] [Abstract][Full Text] [Related]
5. Chemical inhibitor targeting the replication protein A-DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancer.
Mishra AK; Dormi SS; Turchi AM; Woods DS; Turchi JJ
Biochem Pharmacol; 2015 Jan; 93(1):25-33. PubMed ID: 25449597
[TBL] [Abstract][Full Text] [Related]
6. Dynamic binding of replication protein a is required for DNA repair.
Chen R; Subramanyam S; Elcock AH; Spies M; Wold MS
Nucleic Acids Res; 2016 Jul; 44(12):5758-72. PubMed ID: 27131385
[TBL] [Abstract][Full Text] [Related]
7. Targeted inhibition of Replication Protein A reveals cytotoxic activity, synergy with chemotherapeutic DNA-damaging agents, and insight into cellular function.
Shuck SC; Turchi JJ
Cancer Res; 2010 Apr; 70(8):3189-98. PubMed ID: 20395205
[TBL] [Abstract][Full Text] [Related]
8. [Replication protein A as a major eukaryotic single-stranded DNA-binding protein and its role in DNA repair].
Krasikova YS; Rechkunova NI; Lavrik OI
Mol Biol (Mosk); 2016; 50(5):735-750. PubMed ID: 27830676
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative activity and mechanism of action of titanocene dichloride.
Christodoulou CV; Eliopoulos AG; Young LS; Hodgkins L; Ferry DR; Kerr DJ
Br J Cancer; 1998 Jun; 77(12):2088-97. PubMed ID: 9649119
[TBL] [Abstract][Full Text] [Related]
10. Repair-specific functions of replication protein A.
Hass CS; Lam K; Wold MS
J Biol Chem; 2012 Feb; 287(6):3908-18. PubMed ID: 22179778
[TBL] [Abstract][Full Text] [Related]
11. Differential binding kinetics of replication protein A during replication and the pre- and post-incision steps of nucleotide excision repair.
Gourdin AM; van Cuijk L; Tresini M; Luijsterburg MS; Nigg AL; Giglia-Mari G; Houtsmuller AB; Vermeulen W; Marteijn JA
DNA Repair (Amst); 2014 Dec; 24():46-56. PubMed ID: 25453469
[TBL] [Abstract][Full Text] [Related]
12. Chemical Inhibition of RPA by HAMNO Alters Cell Cycle Dynamics by Impeding DNA Replication and G2-to-M Transition but Has Little Effect on the Radiation-Induced DNA Damage Response.
Dueva R; Krieger LM; Li F; Luo D; Xiao H; Stuschke M; Metzen E; Iliakis G
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834389
[TBL] [Abstract][Full Text] [Related]
13. Activity of cisplatin and ICI 182,780 on estrogen receptor negative ovarian cancer cells: cell cycle and cell replication rate perturbation, chromatin texture alteration and apoptosis induction.
Ercoli A; Battaglia A; Raspaglio G; Fattorossi A; Alimonti A; Petrucci F; Caroli S; Mancuso S; Scambia G
Int J Cancer; 2000 Jan; 85(1):98-103. PubMed ID: 10585591
[TBL] [Abstract][Full Text] [Related]
14. Treatment with the Chk1 inhibitor Gö6976 enhances cisplatin cytotoxicity in SCLC cells.
Thompson R; Meuth M; Woll P; Zhu Y; Danson S
Int J Oncol; 2012 Jan; 40(1):194-202. PubMed ID: 21894433
[TBL] [Abstract][Full Text] [Related]
15. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
Mamenta EL; Poma EE; Kaufmann WK; Delmastro DA; Grady HL; Chaney SG
Cancer Res; 1994 Jul; 54(13):3500-5. PubMed ID: 8012973
[TBL] [Abstract][Full Text] [Related]
16. Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells.
Simonin K; Brotin E; Dufort S; Dutoit S; Goux D; N'diaye M; Denoyelle C; Gauduchon P; Poulain L
Mol Cancer Ther; 2009 Nov; 8(11):3162-70. PubMed ID: 19887550
[TBL] [Abstract][Full Text] [Related]
17. RADX interacts with single-stranded DNA to promote replication fork stability.
Schubert L; Ho T; Hoffmann S; Haahr P; Guérillon C; Mailand N
EMBO Rep; 2017 Nov; 18(11):1991-2003. PubMed ID: 29021206
[TBL] [Abstract][Full Text] [Related]
18. Functions of human replication protein A (RPA): from DNA replication to DNA damage and stress responses.
Zou Y; Liu Y; Wu X; Shell SM
J Cell Physiol; 2006 Aug; 208(2):267-73. PubMed ID: 16523492
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.
Liu G; Yang D; Rupaimoole R; Pecot CV; Sun Y; Mangala LS; Li X; Ji P; Cogdell D; Hu L; Wang Y; Rodriguez-Aguayo C; Lopez-Berestein G; Shmulevich I; De Cecco L; Chen K; Mezzanzanica D; Xue F; Sood AK; Zhang W
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25995442
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma.
Mack PC; Gandara DR; Lau AH; Lara PN; Edelman MJ; Gumerlock PH
Cancer Chemother Pharmacol; 2003 Apr; 51(4):337-48. PubMed ID: 12721762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
